SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-012369
Filing Date
2016-08-15
Accepted
2016-08-15 11:36:02
Documents
55
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 994841
2 ex10-1.htm EX-10.1 51355
3 ex31-1.htm EX-31.1 18734
4 ex32-1.htm EX-32.1 5186
  Complete submission text file 0001493152-16-012369.txt   3511101

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE imun-20160630.xml EX-101.INS 498745
6 XBRL SCHEMA FILE imun-20160630.xsd EX-101.SCH 49794
7 XBRL CALCULATION FILE imun-20160630_cal.xml EX-101.CAL 41871
8 XBRL DEFINITION FILE imun-20160630_def.xml EX-101.DEF 113765
9 XBRL LABEL FILE imun-20160630_lab.xml EX-101.LAB 280553
10 XBRL PRESENTATION FILE imun-20160630_pre.xml EX-101.PRE 190318
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 161830930
SIC: 2834 Pharmaceutical Preparations